Evidence map›Paper›PMID 35906015›Full record

Trial reportBMJ global health2022

When do persuasive messages on vaccine safety steer COVID-19 vaccine acceptance and recommendations? Behavioural insights from a randomised controlled experiment in Malaysia.

Nicholas Yee Liang Hing, Yuan Liang Woon, Yew Kong Lee, Hyung Joon Kim, Nurhyikmah M Lothfi, Elizabeth Wong, Komathi Perialathan, Nor Haryati Ahmad Sanusi, Affendi Isa, Chin Tho Leong and 1 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05244356 (Effective Public Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05244356 nacompletednot on this map

Effective Public Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation: A Randomized Controlled Experiment

TypeinterventionalSponsorClinical Research Centre, MalaysiaRan2021 to 2021Enrolled5,784ConditionsCOVID-19, Respiratory Disease, Vaccine Refusal, Infectious DiseaseArmsHealth message exposure
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Microorganisms · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nicholas Yee Liang HingCentre for Clinical Epidemiology, Institute for Clinical Research, National Institutes of Health, Shah Alam, Selangor, Malaysia nicholas.hingyl@gmail.com.ORCID 0000-0003-4530-8466
Yuan Liang WoonCentre for Clinical Epidemiology, Institute for Clinical Research, National Institutes of Health, Shah Alam, Selangor, Malaysia.ORCID 0000-0003-4834-9175
Yew Kong LeeDepartment of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.ORCID 0000-0002-3034-8601
Hyung Joon KimUnited Nations Children's Fund Malaysia, Putrajaya, Malaysia.ORCID 0000-0001-6224-835X
Nurhyikmah M LothfiDepartment of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.ORCID 0000-0002-2307-4075
Elizabeth WongUnited Nations Children's Fund Malaysia, Putrajaya, Malaysia.
Komathi PerialathanCentre for Health Communication and Informatics Research, Institute for Health Behavioural Research, National Institutes of Health, Shah Alam, Selangor, Malaysia.ORCID 0000-0003-3539-8605
Nor Haryati Ahmad SanusiCentre for Health Communication and Informatics Research, Institute for Health Behavioural Research, National Institutes of Health, Shah Alam, Selangor, Malaysia.
Affendi IsaHealth Education Division, Ministry of Health Malaysia, Putrajaya, Malaysia.
Chin Tho LeongCentre for Clinical Epidemiology, Institute for Clinical Research, National Institutes of Health, Shah Alam, Selangor, Malaysia.ORCID 0000-0002-3688-5467
Joan Costa-FontDepartment of Health Policy, The London School of Economics and Political Science, London, UK.ORCID 0000-0001-7174-7919

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionVaccine safety is a primary concern among vaccine-hesitant individuals. We examined how seven persuasive messages with different frames, all focusing on vaccine safety, influenced Malaysians to accept the COVID-19 vaccine, and recommend it to individuals with different health and age profiles; that is, healthy adults, the elderly, and people with pre-existing health conditions.

methodsA randomised controlled experiment was conducted from 29 April to 7 June 2021, which coincided with the early phases of the national vaccination programme when vaccine uptake data were largely unavailable. 5784 Malaysians were randomly allocated into 14 experimental arms and exposed to one or two messages that promoted COVID-19 vaccination. Interventional messages were applied alone or in combination and compared against a control message. Outcome measures were assessed as intent to both take the vaccine and recommend it to healthy adults, the elderly, and people with pre-existing health conditions, before and after message exposure. Changes in intent were modelled and we estimated the average marginal effects based on changes in the predicted probability of responding with a positive intent for each of the four outcomes.

resultsWe found that persuasive communication via several of the experimented messages improved recommendation intentions to people with pre-existing health conditions, with improvements ranging from 4 to 8 percentage points. In contrast, none of the messages neither significantly improved vaccination intentions, nor recommendations to healthy adults and the elderly. Instead, we found evidence suggestive of backfiring among certain outcomes with messages using negative attribute frames, risky choice frames, and priming descriptive norms.

conclusionMessage frames that briefly communicate verbatim facts and stimulate rational thinking regarding vaccine safety may be ineffective at positively influencing vaccine-hesitant individuals. Messages intended to promote recommendations of novel health interventions to people with pre-existing health conditions should incorporate safety dimensions. TRIAL REGISTRATION NUMBER: NCT05244356.

Indexed as

COVID-19Viral VaccinesAdultAgedCOVID-19 VaccinesHumansMalaysiaPersuasive CommunicationCOVID-19 VaccinesViral VaccinesCOVID-19Health education and promotionPublic HealthRandomised control trialVaccines

Identifiers

PMID35906015
PMCPMC9344599

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.